Back
Golub Capital BDC Vs. Aligos Therapeutics Industry Stock Comparison
Buy
66
GBDC
Golub Capital BDC
Last Price:
$15.25
Seasonality Move:
-1.38%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Buy
66
Golub Capital BDC (GBDC)
is a Buy
Is Golub Capital BDC a Buy, Sell or Hold?
-
The current Golub Capital BDC [GBDC] share price is $15.25. The Score for GBDC is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
GBDC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GBDC Stock Price Chart
What is Golub Capital BDC's stock price today?
-
The Golub Capital BDC share price today is $15.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBDC is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $41.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
GBDC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 51.57 | Buy |
Chaikin Money Flow: | -319461 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.99 - 15.51) | Sell |
Bollinger Bands (100): | (14.78 - 15.4) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.69 | Buy |
Relative Strength Index (14 RSI): | 73.75 | Buy |
Chaikin Money Flow: | -154898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.72 - 37.64) | Buy |
Bollinger Bands (100): | (6.81 - 25.85) | Buy |
GBDC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.08 | Buy |
20-day SMA: | 15.23 | Buy |
50-day SMA: | 15.3 | Sell |
200-day SMA: | 15.62 | Sell |
8-day EMA: | 15.17 | Buy |
20-day EMA: | 15.19 | Buy |
50-day EMA: | 15.22 | Buy |
200-day EMA: | 15.3 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.54 | Buy |
20-day SMA: | 33.12 | Buy |
50-day SMA: | 21.28 | Buy |
200-day SMA: | 16.61 | Buy |
8-day EMA: | 38.79 | Buy |
20-day EMA: | 33.47 | Buy |
50-day EMA: | 25.09 | Buy |
200-day EMA: | 18.34 | Buy |
Golub Capital BDC Earnings Growth & GBDC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and a decrease next year of $0.24 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Golub Capital BDC Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |